Involvement of dopamine D1/D2 receptors on harmane-induced amnesia in the step-down passive avoidance test

European Journal of Pharmacology

Volumn 634, Issue 1-3, 2010, Pages 77-83

  Nasehi, Mohammad ^a   Piri, Morteza ^b   Nouri, Maryam ^c   Farzin, Davood ^d   Nayer Nouri, Touraj ^g   Zarrindast, Mohammad Reza ^c,e,f,g  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

^f INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

(Mouse); Anxiety; D1 and D2 receptor antagonist; Harmane; Hole board; Memory; Step down passive avoidance

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HARMAN; SULPIRIDE; BENZAZEPINE DERIVATIVE; DRUG DERIVATIVE; HARMINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; MALE; MEMORY; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; ANIMAL; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; EXPLORATORY BEHAVIOR; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; REACTION TIME;

AMNESIA; ANIMALS; AVOIDANCE LEARNING; BENZAZEPINES; EXPLORATORY BEHAVIOR; HARMINE; MALE; MICE; PILOT PROJECTS; REACTION TIME; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 77951204883     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.02.027     Document Type: Article

References (77)

1. Adachi J., Mizoi Y., Naito T., Yamamoto K., Fujiwara S., Ninomiya I. Determination of beta-carbolines in foodstuffs by high-performance liquid chromatography and high-performance liquid chromatography-mass spectrometry. J. Chromatogr. 1991, 538:331-339.
2. Adell A., Biggs T.A., Myers R.D. Action of harman (1-methyl-beta-carboline) on the brain: body temperature and in vivo efflux of 5-HT from hippocampus of the rat. Neuropharmacology 1996, 35:1101-1107.
3. Adriani W., Felici A., Sargolini F., Roullet P., Usiello A., Oliverio A., Mele A. N-methyl-d-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes. Exp. Brain Res. 1998, 123:52-59.
4. Adriani W., Sargolini F., Coccurello R., Oliverio A., Mele A. Role of dopaminergic system in reactivity to spatial and non-spatial changes in mice. Psychopharmacology (Berl) 2000, 150:67-76.
5. Airaksinen M.M., Ho B.T., An R., Taylor D. Major pharmacological effects of 6-methoxytetrahydro-beta-carboline, a drug elevating the tissue 5-hydroxytryptamine level. Arzneimittelforschung 1978, 28:42-46.
6. Airaksinen M.M., Lecklin A., Saano V., Tuomisto L., Gynther J. Tremorigenic effect and inhibition of tryptamine and serotonin receptor binding by beta-carbolines. Pharmacol. Toxicol. 1987, 60:5-8.
7. Anderson N.J., Robinson E.S., Husbands S.M., Delagrange P., Nutt D.J., Hudson A.L. Characterization of [(3)H]harmane binding to rat whole brain membranes. Ann. N. Y. Acad. Sci. 2003, 1009:175-179.
8. Barrett A.J., Locatelli F., Treleaven J.G., Gratwohl A., Szydlo R., Zwaan F.E. Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party. Br. J. Haematol. 1991, 79:567-574.
9. Baum S.S., Hill R., Rommelspacher H. Harman-induced changes of extracellular concentrations of neurotransmitters in the nucleus accumbens of rats. Eur. J. Pharmacol. 1996, 314:75-82.
10. Boissier J.R., Simon P. The exploration reaction in the mouse. Preliminary note. Therapie 1962, 17:1225-1232.
11. Bonnet J.J., Costentin J. GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo. Eur. J. Pharmacol. 1986, 121:199-209.
12. Civelli O., Bunzow J.R., Grandy D.K. Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. Toxicol. 1993, 33:281-307.
13. Coccurello R., Adriani W., Oliverio A., Mele A. Effect of intra-accumbens dopamine receptor agents on reactivity to spatial and non-spatial changes in mice. Psychopharmacology (Berl) 2000, 152:189-199.
14. Davis P.A., Baird-Lambert J., Taylor K.M., Maclaren J.A. Serotonergic activity of a novel tetrahydro-beta-carboline. Biochem. Pharmacol. 1979, 28:1803-1806.
15. de Montigny C., Lamarre Y. Rhythmic activity induced by harmaline in the olivo-cerebello-bulbar system of the cat. Brain Res. 1973, 53:81-95.
16. Du W., Harvey J.A. Harmaline-induced tremor and impairment of learning are both blocked by dizocilpine in the rabbit. Brain Res. 1997, 745:183-188.
17. Duterte-Boucher D., Kamenka J.M., Costentin J. Comparison of the effects of three indirect dopamine agonists, GK 13, GBR 12783 and dexamphetamine on behavioural tests involving central catecholaminergic transmissions. Psychopharmacology (Berl) 1990, 101:344-353.
18. el Bahri L., Chemli R. Peganum harmala L: a poisonous plant of North Africa. Vet. Hum. Toxicol. 1991, 33:276-277.
19. Ergene E., Schoener E.P. Effects of harmane (1-methyl-beta-carboline) on neurons in the nucleus accumbens of the rat. Pharmacol. Biochem. Behav. 1993, 44:951-957.
20. Fernandez de Arriba A., Lizcano J.M., Balsa M.D., Unzeta M. Inhibition of monoamine oxidase from bovine retina by beta-carbolines. J. Pharm. Pharmacol. 1994, 46:809-813.
21. Fuller R.W., Wong C.J., Hemrick-Luecke S.K. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice. Life Sci. 1986, 38:409-412.
22. Gingrich J.A., Caron M.G. Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 1993, 16:299-321.
23. Glennon R.A., Dukat M., Grella B., Hong S., Costantino L., Teitler M., Smith C., Egan C., Davis K., Mattson M.V. Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors. Drug Alcohol Depend. 2000, 60:121-132.
24. Honecker H., Coper H., Fahndrich C., Rommelspacher H. Identification of tetrahydronorharmane (tetrahydro-beta-carboline) in human blood platelets. J. Clin. Chem. Clin. Biochem. 1980, 18:133-135.
25. Hudson A.L., Gough R., Tyacke R., Lione L., Lalies M., Lewis J., Husbands S., Knight P., Murray F., Hutson P., Nutt D.J. Novel selective compounds for the investigation of imidazoline receptors. Ann. N. Y. Acad. Sci. 1999, 881:81-91.
26. Hyttel J. Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390. Neuropharmacology 1984, 23:1395-1401.
27. Ichihara K., Nabeshima T., Kameyama T. Effects of haloperidol, sulpiride and SCH 23390 on passive avoidance learning in mice. Eur. J. Pharmacol. 1988, 151:435-442.
28. Jay T.M. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog. Neurobiol. 2003, 69:375-390.
29. Johnston A.L., File S.E. Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites. Pharmacol. Biochem. Behav. 1989, 32:151-156.
30. Kalivas P.W., Abhold R. Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine. Brain Res. 1987, 414:339-348.
31. Kameyama T., Nabeshima T., Kozawa T. Step-down-type passive avoidance- and escape-learning method. Suitability for experimental amnesia models. J. Pharmacol. Methods 1986, 16:39-52.
32. Kari I., Rapakko S., Airaksinen M.M. Effect of some beta-carbolines on phenylethylamine and apomorphine stereotypies in rats. Pharmacol. Biochem. Behav. 1980, 12:979-982.
33. Kim D.H., Jang Y.Y., Han E.S., Lee C.S. Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells. Eur. J. NeuroSci. 2001, 13:1861-1872.
34. Kleven M.S., Woolverton W.L. Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys. Drug Alcohol Depend. 1993, 31:149-158.
35. Komulainen H., Tuomisto J., Airaksinen M.M., Kari I., Peura P., Pollari L. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes. Acta Pharmacol. Toxicol. (Copenh) 1980, 46:299-307.
36. Kuhn W., Muller T., Gerlach M., Sofic E., Fuchs G., Heye N., Prautsch R., Przuntek H. Depression in Parkinson's disease: biogenic amines in CSF of "de novo" patients. J. Neural. Transm. 1996, 103:1441-1445.
37. Lamarre Y., Mercier L.A. Neurophysiological studies of harmaline-induced tremor in the cat. Can. J. Physiol. Pharmacol. 1971, 49:1049-1058.
38. Louis E.D., Zheng W., Jurewicz E.C., Watner D., Chen J., Factor-Litvak P., Parides M. Elevation of blood beta-carboline alkaloids in essential tremor. Neurology 2002, 59:1940-1944.
39. Maher P., Davis J.B. The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 1996, 16:6394-6401.
40. May T., Greube A., Strauss S., Heineke D., Lehmann J., Rommelspacher H. Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla. Naunyn Schmiedebergs Arch. Pharmacol. 1994, 349:308-317.
41. McCormick S.J., Tunnicliff G. Inhibitors of synaptosomal gamma-hydroxybutyrate transport. Pharmacology 1998, 57:124-131.
42. Mehta H., Saravanan K.S., Mohanakumar K.P. Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice. Behav. Brain Res. 2003, 145:31-36.
43. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 1998, 78:189-225.
44. Myers R.D., Melchior C.L. Differential actions on voluntary alcohol intake of tetrahydroisoquinolines or a beta-carboline infused chronically in the ventricle of the rat. Pharmacol. Biochem. Behav. 1977, 7:381-392.
45. Pahkla R., Rago L., Callaway J.J., Airaksinen M.M. Binding of pinoline on the 5-hydroxytryptamine transporter: competitive interaction with [3H] citalopram. Pharmacol. Toxicol. 1997, 80:122-126.
46. Pich E.M., Samanin R. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine. Psychopharmacology (Berl) 1986, 89:125-130.
47. Pranzatelli M.R., Snodgrass S.R. Harmala alkaloids and related beta-carbolines: a myoclonic model and antimyoclonic drugs. Exp. Neurol. 1987, 96:703-719.
48. Rezayof A., Amini R., Rassouli Y., Zarrindast M.R. Influence of nitric oxide on morphine-induced amnesia and interactions with dopaminergic receptor agents. Physiol. Behav. 2006, 88:124-131.
49. Rezayof A., Motevasseli T., Rassouli Y., Zarrindast M.R. Dorsal hippocampal dopamine receptors are involved in mediating ethanol state-dependent memory. Life Sci. 2007, 80:285-292.
50. Rodgers R.J., Nikulina E.M., Cole J.C. Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze. Pharmacol. Biochem. Behav. 1994, 49:985-995.
51. Rodriguez Echandia E.L., Broitman S.T., Foscolo M.R. Effect of the chronic ingestion of chlorimipramine and desipramine on the hole board response to acute stresses in male rats. Pharmacol. Biochem. Behav. 1987, 26:207-210.
52. Rommelspacher H., Kauffmann H., Cohnitz C.H., Coper H. Pharmacological properties of tetrahydronorharmane (tryptoline). Naunyn Schmiedebergs Arch. Pharmacol. 1977, 298:83-91.
53. Rommelspacher H., Nanz C., Borbe H.O., Fehske K.J., Muller W.E., Wollert U. 1-Methyl-beta-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding. Naunyn Schmiedebergs Arch. Pharmacol. 1980, 314:97-100.
54. Rommelspacher H., Nanz C., Borbe H.O., Fehske K.J., Muller W.E., Wollert U. Benzodiazepine antagonism by harmane and other beta-carbolines in vitro and in vivo. Eur. J. Pharmacol. 1981, 70:409-416.
55. Rommelspacher H., Buchau C., Weiss J. Harman induces preference for ethanol in rats: is the effect specific for ethanol?. Pharmacol. Biochem. Behav. 1987, 26:749-755.
56. Rommelspacher H., May T., Susilo R. Beta-carbolines and tetrahydroisoquinolines: detection and function in mammals. Planta Med. 1991, 57:S85-S92.
57. Rommelspacher H., Schmidt L.G., May T. Plasma norharman (beta-carboline) levels are elevated in chronic alcoholics. Alcohol. Clin. Exp. Res. 1991, 15:553-559.
58. Rommelspacher H., May T., Salewski B. Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats. Eur. J. Pharmacol. 1994, 252:51-59.
59. Rommelspacher H., Meier-Henco M., Smolka M., Kloft C. The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets. Eur. J. Pharmacol. 2002, 441:115-125.
60. Russell K.H., Hagenmeyer-Houser S.H., Sanberg P.R. Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome. Psychopharmacology (Berl) 1987, 91:45-49.
61. Sanberg P.R. Neuroleptic-induced emotional defecation: effects of pimozide and apomorphine. Physiol. Behav. 1989, 46:199-202.
62. Seeman P., Van Tol H.H. Dopamine receptor pharmacology. Curr. Opin. Neurol. Neurosurg. 1993, 6:602-608.
63. Simon P., Panissaud C., Costentin J. Anxiogenic-like effects induced by stimulation of dopamine receptors. Pharmacol. Biochem. Behav. 1993, 45:685-690.
64. Spijkerman R., van den Eijnden R., van de Mheen D., Bongers I., Fekkes D. The impact of smoking and drinking on plasma levels of norharman. Eur. Neuropsychopharmacol. 2002, 12:61-71.
65. Stohler R., Hug I., Knoll B., Mohler B., Ladewig D. Initial results with withdrawal treatments of male and female participants in the diversified Janus opiate prescription project in Basel. Praxis 1996, 85:1537-1541.
66. Stoof J.C., Kebabian J.W. Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 1984, 35:2281-2296.
67. Susilo R., Damm H., Rommelspacher H., Hofle G. Biotransformation of 1-methyl-1, 2, 3, 4-tetrahydro-beta-carboline-1-carboxylic acid to harmalan, tetrahydroharman and harman in rats. Neurosci. Lett. 1987, 81:325-330.
68. Talalaenko A.N., Abramets I.A., Stakhovskii Yu V., Shekhovtsov A.A., Chernikov A.V., Shevchenko S.L. The role of dopaminergic mechanisms on the brain in various models of anxious states. Neurosci. Behav. Physiol. 1994, 24:284-288.
69. Taylor D.L., Silverman P.B., Ho B.T. Effects of 6-methoxytetrahydro-beta-carboline on 5-hydroxytryptamine binding in rat brain. J. Pharm. Pharmacol. 1984, 36:125-127.
70. Tella S.R. Effects of monoamine reuptake inhibitors on cocaine self-administration in rats. Pharmacol. Biochem. Behav. 1995, 51:687-692.
71. Vinade E.R., Schmidt A.P., Frizzo M.E., Izquierdo I., Elisabetsky E., Souza D.O. Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice. Brain Res. 2003, 977:97-102.
72. Welsh J.P. Systemic harmaline blocks associative and motor learning by the actions of the inferior olive. Eur. J. NeuroSci. 1998, 10:3307-3320.
73. Welsh J.P., Harvey J.A. Acute inactivation of the inferior olive blocks associative learning. Eur. J. NeuroSci. 1998, 10:3321-3332.
74. Witkin J.M., Perez L.A. Comparison of effects of buspirone and gepirone with benzodiazepines and antagonists of dopamine and serotonin receptors on punished behavior of rats. Behav. Pharmacol. 1989, 1:247-254.
75. Zarrindast M.R., Rezayof A. Morphine state-dependent learning: sensitization and interactions with dopamine receptors. Eur. J. Pharmacol. 2004, 497:197-204.
76. Zarrindast M.R., Lahmi A., Ahamadi S. Possible involvement of mu-opioid receptors in effect of lithium on inhibitory avoidance response in mice. J. Psychopharmacol. 2008, 22:865-871.
77. Zarrindast M., Madadi F., Ahmadi S. Repeated administrations of dopamine receptor agents affect lithium-induced state-dependent learning in mice. J. Psychopharmacol. 2009, 23:645-651.